Bank of New York Mellon Corp
BankPosition in CTMX — CytomX Therapeutics, Inc.
CIK 1390777
NEW YORK, NY
Position in CTMX
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$2,567,019
+$1,204,641 QoQ
Shares Held
684,539
+136.2% QoQ
Ownership
0.314%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#36
of 178 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 95%
Shared 0%
None 5%
Common Shares in CTMX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Bank of New York Mellon Corp holds $4,845,290,998 across 311 Biotechnology names. CTMX ranks #135 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,672,623 | $830,842,010 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
758,492 | $472,950,091 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
1,578,013 | $380,253,782 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
492,071 | $148,128,128 | |
| 5 | INSM |
INSMED Inc
|
1,312,756 | $139,966,036 | |
| 6 | MRNA |
Moderna, Inc.
|
1,701,675 | $119,168,293 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
601,056 | $112,565,759 | |
| 8 | INCY |
Incyte Corp
|
972,825 | $110,279,435 |
All Filings in CTMX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,567,019 | 684,539 | Shares | Defined | 2026-08-06 | |
| 2026-03-31 | $1,362,378 | 289,868 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $1,398,335 | 328,248 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $805,981 | 252,659 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $573,534 | 252,659 | Shares | Defined | 2025-08-05 | |
| 2025-03-31 | $153,897 | 241,980 | Shares | Defined | 2025-04-29 | |
| 2024-12-31 | $249,239 | 241,980 | Shares | Defined | 2025-02-04 | |
| 2024-09-30 | $285,537 | 241,982 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $295,216 | 241,982 | Shares | Defined | 2024-07-25 | |
| 2024-03-31 | $527,517 | 241,981 | Shares | Defined | 2024-04-25 | |
| 2023-12-31 | $413,595 | 266,836 | Shares | Defined | 2024-01-29 | |
| 2023-09-30 | $344,218 | 266,836 | Shares | Defined | 2023-10-24 | |
| 2023-06-30 | $54,809 | 31,866 | Shares | Defined | 2023-08-03 | |
| 2023-03-31 | $54,589 | 36,152 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $57,843 | 36,152 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $52,468 | 36,185 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $66,218 | 36,185 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $566,821 | 212,293 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $922,657 | 213,085 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $1,069,341 | 210,087 | Shares | Defined | 2021-11-18 | |
| 2021-06-30 | $1,231,159 | 194,496 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $1,524,633 | 197,236 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $1,155,491 | 176,411 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $1,207,759 | 181,618 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $1,508,428 | 181,084 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $1,497,420 | 195,231 | Shares | Defined | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||